ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 571,57
0,91%
Dow Jones
38 778,10
0,49%
DAX
18 068,21
0,26%
Brent Oil
83,88
2,14%
Bitcoin
66 557,31
-0,12%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Capstone Therapeutics Corp (MM) (CAPS)

  7. Capstone Therapeutics Corp (MM) (CAPS) Actualités

CAPS

Capstone Therapeutics Corp (MM) (CAPS)

Capstone Therapeutics Corp (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CAPS
DateHeureSourceTitreSymboleSociété
07/05/201815h00GlobeNewswire Inc.LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, ChinaNASDAQ:CAPSCapstone Therapeutics Corp (MM)
20/07/201112h03Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
19/07/201100h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
06/07/201114h00GlobeNewswire Inc.Capstone Therapeutics Announces Pre-Clinical Results With AZX100 in Radiation and Bleomycin Models of Pulmonary Fibrosis; PulmonNASDAQ:CAPSCapstone Therapeutics Corp (MM)
09/06/201119h21Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-A12B/A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
08/06/201118h31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
08/06/201118h30GlobeNewswire Inc.Capstone Therapeutics Announces Adjournment of Its Annual Meeting of Stockholders and Intention to Reconvene the Meeting on JuneNASDAQ:CAPSCapstone Therapeutics Corp (MM)
31/05/201120h00GlobeNewswire Inc.Capstone Therapeutics Signs Alliance With BiolineRx to Develop Chrysalin (TP508) in Acute Myocardial InfarctionNASDAQ:CAPSCapstone Therapeutics Corp (MM)
26/05/201123h00GlobeNewswire Inc.Capstone Therapeutics Reminds Stockholders of Annual Meeting on June 6, 2011 and Encourages All Stockholders to VoteNASDAQ:CAPSCapstone Therapeutics Corp (MM)
13/05/201115h00Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
29/04/201121h12Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
27/04/201122h45GlobeNewswire Inc.Capstone Therapeutics Confirms Early Signal of AZX100 Effect Based on Final Results of Phase 2a Pilot Clinical Trial in SurgicalNASDAQ:CAPSCapstone Therapeutics Corp (MM)
04/04/201122h05GlobeNewswire Inc.Capstone Therapeutics Announces Update to Timing of Release of Final Results From AZX100 Phase 2a Pilot Clinical Trial in SurgicNASDAQ:CAPSCapstone Therapeutics Corp (MM)
29/03/201115h02Edgar (US Regulatory)Annual Report (10-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
11/02/201119h11Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
06/01/201122h52GlobeNewswire Inc.Capstone Therapeutics to Present at Biotech Showcase 2011NASDAQ:CAPSCapstone Therapeutics Corp (MM)
14/12/201003h18GlobeNewswire Inc.Capstone Therapeutics Announces Results of AZX100 Phase 2a Pilot Clinical Trials in Keloid and Surgical ScarringNASDAQ:CAPSCapstone Therapeutics Corp (MM)
08/12/201023h00GlobeNewswire Inc.Capstone Therapeutics to Host AZX100 Clinical Update TeleconferenceNASDAQ:CAPSCapstone Therapeutics Corp (MM)
10/11/201012h00GlobeNewswire Inc.Capstone Therapeutics Announces Third Quarter 2010 Financial ResultsNASDAQ:CAPSCapstone Therapeutics Corp (MM)
03/11/201014h00GlobeNewswire Inc.Capstone Therapeutics to Host Quarterly Update Conference CallNASDAQ:CAPSCapstone Therapeutics Corp (MM)
02/10/201001h45GlobeNewswire Inc.Capstone Therapeutics to Present at 9th Annual BIO Investor ForumNASDAQ:CAPSCapstone Therapeutics Corp (MM)
13/09/201019h00GlobeNewswire Inc.Capstone Therapeutics Announces Progress in Clinical Trials of AZX100 in Keloid ScarringNASDAQ:CAPSCapstone Therapeutics Corp (MM)
07/09/201019h00GlobeNewswire Inc.Capstone Therapeutics to Present at Rodman & Renshaw 12th Annual Healthcare ConferenceNASDAQ:CAPSCapstone Therapeutics Corp (MM)
09/08/201013h00GlobeNewswire Inc.Capstone Therapeutics Announces Second Quarter 2010 Financial ResultsNASDAQ:CAPSCapstone Therapeutics Corp (MM)
06/07/201014h00GlobeNewswire Inc.Capstone Therapeutics Announces Continuation of AZX100 Phase 2 Clinical Trial in Dermal Scarring Following Shoulder SurgeryNASDAQ:CAPSCapstone Therapeutics Corp (MM)
25/05/201022h17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
24/05/201013h00GlobeNewswire Inc.Capstone Therapeutics Corp. Appoints Robert J. Spiegel, MD to Board of DirectorsNASDAQ:CAPSCapstone Therapeutics Corp (MM)
21/05/201019h07GlobeNewswire Inc.Capstone Therapeutics Corp. Announces Stockholder Approval of "Put Right" and Name Change; Management to Host Conference CallNASDAQ:CAPSCapstone Therapeutics Corp (MM)
14/05/201020h00GlobeNewswire Inc.Capstone Therapeutics to Present at Rodman & Renshaw 6th Annual Global Healthcare ConferenceNASDAQ:CAPSCapstone Therapeutics Corp (MM)
12/05/201013h00GlobeNewswire Inc.Capstone Therapeutics Announces Continuation of Second of Two AZX100 Phase 2 Clinical Trials in Keloid ScarringNASDAQ:CAPSCapstone Therapeutics Corp (MM)
 Showing the most relevant articles for your search:NASDAQ:CAPS

Dernières Valeurs Consultées

NASDAQ
MSFT
Microsoft
COIN
BTCUSD
Bitcoin
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
EU
BN
Danone
EU
AF
Air FranceKLM
EU
SGO
Cie de SaintGobain
EU
LR
Legrand
EU
RI
Pernod Ricard
COIN
ETHUSD
Ethereum
EU
ACA
Credit Agricole
EU
ORA
Orange
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés